小分子诱导的蛋白质聚合:机制和治疗影响
Young-Sool Hah1, Sun-Young Han2
1Biomedical Research Institute, Gyeongsang National University Hospital, Jinju 52727, Republic of Korea.
Biomolecules & therapeutics
|August 12, 2025
概括
诱导蛋白质聚合的小分子提供了新的治疗途径. 本综述详细介绍了五种化合物,探讨了它们在疾病治疗中蛋白质降解,激活或稳定的各种机制.
科学领域:
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
- 分子生物学分子生物学
背景情况:
- 诱导蛋白质聚合的小分子是一个新兴的治疗类.
- 这些化合物向各种蛋白质,包括PML-RARα,BCL6,STING,β-tubulin和p62.
- 蛋白质聚合在细胞功能和疾病发病过程中起着至关重要的作用.
研究的目的:
- 为五种诱导蛋白质聚合的小分子提供全面的概述.
- 探索它们独特的分子机制,结构洞察力和治疗潜力.
- 突出在向蛋白质降解,癌症治疗和细胞过程调制中的应用.
主要方法:
- 关于三氧化 (As2O3),BI-3802,NVS-STG2,帕克利塔克塞尔和脊柱的现有文献的审查.
- 分析它们的蛋白标和诱导聚合的机制.
- 检查它们在各种疾病中的治疗含义.
主要成果:
- 三氧化和BI-3802诱导蛋白质降解的聚合.
- NVS-STG2通过聚合激活蛋白质功能.
- 帕克利塔克塞尔稳定了素聚合物,而脊素则导致了共价交叉链接.
结论:
- 这些小分子的多样化机制凸显了蛋白质聚合在健康和疾病中的复杂性.
- 这些化合物为向蛋白质降解和新的治疗策略提供了重大潜力.
- 对蛋白质聚合调节器的进一步研究可以推动药物发现和开发.
相关概念视频
ATP and Macromolecule Synthesis
6.1K
Biological macromolecules are organic compounds, predominantly composed of carbon atoms. The carbon atoms are covalently bonded with hydrogen, oxygen, nitrogen, and other minor elements. There are four major biological macromolecule classes: carbohydrates, lipids, proteins, and nucleic acids.
Most macromolecules are composed of single subunits, or building blocks, called monomers. The monomers combine with each other using covalent bonds to form larger molecules known as polymers.
Conversion of...
Most macromolecules are composed of single subunits, or building blocks, called monomers. The monomers combine with each other using covalent bonds to form larger molecules known as polymers.
Conversion of...
6.1K
Covalently Linked Protein Regulators
7.2K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
7.2K
Ligand Binding Sites
13.2K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
13.2K
Protein-Drug Binding: Mechanism and Kinetics
942
Protein-drug binding refers to the interaction between drugs and proteins within the body. This binding process can occur intracellularly, involving drug interactions with enzymes or receptors within cells, or extracellularly, involving plasma proteins in the blood.
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
942
Ligand Binding and Linkage
4.9K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.9K
Cooperative Allosteric Transitions
8.0K
Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
8.0K


